SPHERES, a real-world registry for neuromyelitis optica spectrum disorder (NMOSD), is now collecting biological samples from consenting participants. Launched by CorEvitas and the Guthy-Jackson Charitable Foundation (GJCF) in 2021, the registry had been collecting long-term clinical data, but not biological samples. “The launch of this biospecimen…
SPHERES registry
SPHERES, a real-world registry designed to better understand neuromyelitis optica spectrum disorder (NMOSD) — its underlying mechanisms, clinical course, and treatment effects — has reached a milestone of 200 enrolled patients. Standing for Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD, the SPHERES…
The SPHERES registry, an observational study to better understand the underlying mechanisms and clinical course of neuromyelitis optica spectrum disorder (NMOSD), as well as effects of current treatments, has enrolled its first patient. SPHERES, which stands for Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD,…
CorEvitas and the Guthy-Jackson Charitable Foundation (GJCF) announced plans to launch a registry study for people with neuromyelitis optica spectrum disorder (NMOSD). Called SPHERES — which stands for Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD — the observational study is expected to…
Recent Posts
- Short course of approved drug effective for treatment-resistant NMOSD
- How to help people in your social circle better understand chronic illness
- New NMOSD study points to silent brain changes between relapses
- Working with a pain management clinic feels like a new world of possibility
- My summer vacation tips for traveling with NMOSD